PEN Q2 2021 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$184M+75.3% YoY

Gross Profit

$119M64.4% margin

Operating Income

$10M5.6% margin

Net Income

$9M5.0% margin

EPS (Diluted)

$0.25

QoQ Revenue Growth

+8.9%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$7M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$910M

Total Liabilities

$237M

Stockholders' Equity

$679M

Cash & Equivalents

$82M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$184M	$105M	+75.3%
Gross Profit	$119M	$65M	+82.8%
Operating Income	$10M	-$18M	+158.4%
Net Income	$9M	-$12M	+177.2%

Revenue Segments

Peripheral Vascular

$101M55%

Neuro

$84M45%

Geographic Segments

UNITED STATES

$128M70%

Other Non-US

$56M30%